Medical Use of Byproduct Material

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Nuclear Regulatory Commission 10 CFR Parts 20, 32, and 35 RIN 3150-AF74 AGENCY: Nuclear Regulatory Commission. ACTION: Final rule. SUMMARY: The Nuclear Regulatory Commission (NRC) is amending its regulations regarding the medical use of byproduct material. This final rule is one component of the Commission's overall program for revising its regulatory framework for medical use. The overall goals of this program are to focus NRC's regulations on those medical procedures that pose the highest risk to workers, patients, and the public, and to structure its regulations to be more risk-informed and more performance-based, consistent with the NRC's “Strategic Plan for Fiscal Year 1997-Fiscal Year 2002.” EFFECTIVE DATE: This regulation becomes effective on October 24, 2002. ADDRESSES: Documents related to this rulemaking may be examined at the NRC Public Document Room, One White Flint North, 11555 Rockville Pike, Room O-1 F23, Rockville, MD 20852. Available documents include the final environmental assessment, regulatory analysis, regulatory flexibility analysis, and NUREG-1556, Vol. 9(draft), “Consolidated Guidance About Materials Licenses: Program Specific Guidance About Medical Use Licenses.” Documents created or received at the NRC after November 1, 1999, are also available electronically at the NRC's Public Electronic Reading Room on the Internet at http://www.nrc.gov/​reading-rm.html . From this site, the public can gain entry into the NRC's Agenc…